200 related articles for article (PubMed ID: 18057232)
21. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.
Longnecker R; Miller CL; Miao XQ; Marchini A; Kieff E
J Virol; 1992 Nov; 66(11):6461-9. PubMed ID: 1328675
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R
PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156
[TBL] [Abstract][Full Text] [Related]
23. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.
Shah KM; Stewart SE; Wei W; Woodman CB; O'Neil JD; Dawson CW; Young LS
Oncogene; 2009 Nov; 28(44):3903-14. PubMed ID: 19718044
[TBL] [Abstract][Full Text] [Related]
24. Methylation and expression of Epstein-Barr virus latent membrane protein 1, 2A and 2B in EBV-associated gastric carcinomas and cell lines.
Li J; Liu X; Liu M; Che K; Luo B
Dig Liver Dis; 2016 Jun; 48(6):673-80. PubMed ID: 27026080
[TBL] [Abstract][Full Text] [Related]
25. The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.
Portis T; Cooper L; Dennis P; Longnecker R
Front Biosci; 2002 Feb; 7():d414-26. PubMed ID: 11815296
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.
Miller CL; Lee JH; Kieff E; Burkhardt AL; Bolen JB; Longnecker R
Infect Agents Dis; 1994; 3(2-3):128-36. PubMed ID: 7812651
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
29. The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling.
Ikeda M; Longnecker R
Virology; 2009 Mar; 385(1):183-91. PubMed ID: 19081591
[TBL] [Abstract][Full Text] [Related]
30. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
Swart R; Fruehling S; Longnecker R
Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation.
Fukuda M; Longnecker R
J Virol; 2005 Jul; 79(13):8655-60. PubMed ID: 15956608
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
Portis T; Longnecker R
Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
[TBL] [Abstract][Full Text] [Related]
34. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
35. Two Pathways of p27
Sora RP; Ikeda M; Longnecker R
mBio; 2019 Apr; 10(2):. PubMed ID: 30992353
[TBL] [Abstract][Full Text] [Related]
36. Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus.
Rivailler P; Quink C; Wang F
J Virol; 1999 Oct; 73(10):8867-72. PubMed ID: 10482645
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.
Miller CL; Longnecker R; Kieff E
J Virol; 1993 Jun; 67(6):3087-94. PubMed ID: 7684459
[TBL] [Abstract][Full Text] [Related]
38. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
39. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
Swart R; Ruf IK; Sample J; Longnecker R
J Virol; 2000 Nov; 74(22):10838-45. PubMed ID: 11044134
[TBL] [Abstract][Full Text] [Related]
40. The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.
Merchant M; Swart R; Katzman RB; Ikeda M; Ikeda A; Longnecker R; Dykstra ML; Pierce SK
Int Rev Immunol; 2001; 20(6):805-35. PubMed ID: 11913951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
